Health Care/Hospital

Planetree's Person-Centered Care Certification Standards Achieve International Recognition for Quality

DERBY, Conn., Feb. 15, 2024 /PRNewswire/ -- Planetree's Person-Centered Care Certification® standards have been recognized by the International Society for Quality in Health Care's External Evaluation Association (ISQua EEA). This marks the first time a set of quality standards for person-centere...

2024-02-15 23:00 1520

Kim Byoung Joon LEDAS Varicose Vein Clinic Becomes the First Organization to be Accredited under GHA Standards for Medical Travel 5.0

PALM BEACH GARDENS, Fla., Feb. 15, 2024 /PRNewswire/ -- In a significant achievement that firmly underscores its commitment to the highest standards of healthcare, Kim Byoung Joon LEDAS Varicose Vein Clinic ( https://www.kbjledas.com/) in Busan, South Korea, has been awarded the distinguished Acc...

2024-02-15 19:00 1652

Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED.

CASTRES, France and GENEVA, Feb. 15, 2024 /PRNewswire/ -- On February 20, International Ectodermal Dysplasias Awareness Day, Pierre Fabre Laboratories and the EspeRare Foundation will receive the EURORDIS Company Award for Patient Engagement 2024, at the EURORDIS Black Pearl Award Ceremony to be ...

2024-02-15 17:05 1738

Pharus Diagnostics Signs Worldwide Exclusive License Agreement with City of Hope for Novel Biomarkers to Be Used in Liquid Biopsy Screening for Early Pancreatic Cancer Diagnosis

LOS ANGELES, Feb. 15, 2024 /PRNewswire/ -- Pharus Diagnostics ("PharusDx") today announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be used in early screening of individuals at risk for pancreatic ductal adenocarcinoma (PDAC). This license...

2024-02-15 16:05 1708

iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology

▶ Robot Bacteriophage against microbiome associated with colorectal cancer ▶ Bacteriophage Improvement Platform technology with a broad antimicrobial activity ▶ Proprietary Technology incorporating CRISPR/Cas Technology BOSTON, Feb. 14, 2024 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.i...

2024-02-15 11:37 1299

STARmed to Accelerate Global Market Entry of EUSRA and ELRA Products through Olympus

SEOUL, South Korea, Feb. 14, 2024 /PRNewswire/ -- STARmed, a leading developer and manufacturer of medical devices for tumor ablation, today announced global market expansion of its EUSRA and ELRA products, throughOlympus , a global MedTech company based in Japan....

2024-02-14 22:00 866

Sky Labs' CART BP Becomes the World's First to Complete Comparative Studies with All Blood Pressure Measurement Methods

- The only cuffless blood pressure monitor to complete comparative studies with three types of existing blood pressure measurement methods and prove even accuracy - 24-hour Ambulatory Blood Pressure Monitoring is the first pilot research to reflect ESH recommendations in 2023 SEOUL, South K...

2024-02-14 21:00 1332

YS Biopharma Announces Appointment of New Directors

GAITHERSBURG, Md., Feb. 14, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccin...

2024-02-14 20:50 3389

GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024

* Recent updates on its development of LSD treatments were presented YONGIN, South Korea, Feb. 14, 2024 /PRNewswire/ -- GC Biopharma (CEO, Eun-Chul Huh), a South Korean biopharmaceutical company, announced onFeb. 14th that it has presented the development updates on its LSD (Lysosomal Storage D...

2024-02-14 16:33 1516

Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate Technology Transfer to Expand Clinical and Commercial Supplies

Acquiring all intellectual properties relating to BRII-179 and eliminating future milestone and royalty payments to VBI, subject to achievement of certain activities Transferring manufacturing technologies of BRII-179 and PreHevbrio/PreHevbri to additional manufacturing sites and expanding footp...

2024-02-14 08:07 3586

PCA 500™-- the world's most efficient and versatile 12-lead ECG, receives FDA clearance for use in acute care

LOS ANGELES, Feb. 13, 2024 /PRNewswire/ -- QT Medical, a medtech company focusing on improving cardiac care with electrocardiogram (ECG or EKG), announces that it has received 510(k) clearance from the FDA for PCA 500™ use in acute care. PCA 500 was first 510(k) cleared in 2018 for professional a...

2024-02-14 00:30 1267

Datasea Reports Second Quarter Fiscal Year 2024 Financial Results and Operations Update - Second Quarter Revenue is $11.3 Million Versus $0.1 Million in the Year-Ago Period

BEIJING, Feb. 13, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a global technology company that develops and provides products utilizing intelligent acoustics including ultrasound, infrasound and directional sound, and provides 5G multimodal communication, upgrad...

2024-02-13 22:35 3648

Health In Tech Takes eDIYBS to the 2024 HCAA Executive Forum

Health In Tech leadership to connect with health industry leaders about the  cutting-edge eDIYBS quoting platform. STUART, Fla., Feb. 13, 2024 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and re-imagines self-funded health plans, is att...

2024-02-13 21:30 1269

Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³

Strong CSL Behring portfolio growth especially Ig FINANCIAL HIGHLIGHTS4 * Revenue $8.05 billion, up 11% at CC3 * NPAT $1.90 billion1, up 17% * NPAT $1.94 billion1 at CC3, up 20% * NPATA $2.02 billion1,2 , up 11% * NPATA $2.06 billion1,2 at CC3, up 13% * NPATA1,2 earnings per share $4.1...

2024-02-13 14:21 3659

Ajinomoto Co. Launches Silicon Valley CVC HQ to Grow U.S. Investments, Adds New Portfolios

TOKYO, Feb. 13, 2024 /PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co."), the Japan-based multinational corporation covering food, healthcare and electronic materials, and built on "AminoScience," (*) has expanded its corporate venture capital (CVC) arm with new U.S. headquarters to grow its in...

2024-02-13 14:00 1453

Medical Tourism Patient Survey 2024 Shares Deep Insights into Barriers to Patient Acquisition

WEST PALM BEACH, Fla., Feb. 13, 2024 /PRNewswire/ -- The Medical Tourism Association (MTA) has recently released theMedical Tourism Patient Survey 2024, which provides invaluable insights into the motivations behind healthcare consumers' medical travel decisions and the barriers to patient inflow...

2024-02-13 06:47 1640

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

VANCOUVER, BC, Feb. 13, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has executed the definitive  Asset Purchase Agreement datedFebruary 11th, 2024 to acquire the entire portfolio of discovery, preclinical and cli...

2024-02-13 03:26 3734

United Imaging Ramps Up U.S. Hiring, Opens a Seattle Office

The company continues to build strength in the U.S. market, already present in 35 states in its sixth year. HOUSTON, Feb. 12, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is off to a fast start again in 2024, with 71 o...

2024-02-12 23:00 1293

CeraVe Collaborates with Michael Cera and TikTok Stars on First-of-its-Kind Global Campaign

#1 Gen Z skincare brand in the U.S. goes big with hilarious campaign reinforcing CeraVe is developed with dermatologists notMichael Cera. NEW YORK, Feb. 12, 2024 /PRNewswire/ -- CeraVe, the #1 dermatologist-recommended skincare brand in the US, has revealed the epic conclusion to its inaugural S...

2024-02-12 21:23 2343

Frost & Sullivan Recognizes Innovaccer for Enabling Value-Based Care with Its AI and Advanced Analytics

Innovaccer's AI-powered VBC solution suite unifies patient data seamlessly across diverse systems and care settings, empowering healthcare organizations with innovative, scalable applications. SAN ANTONIO, Feb. 12, 2024 /PRNewswire/ -- After evaluating the revenue cycle management (RCM) industry...

2024-02-12 21:00 1689
1 ... 29303132333435 ... 807